Key result
The TRPM4 p.I376T variant did not alter electrical activity in young murine hearts but significantly decreased the amount of highly glycosylated TRPM4 protein expressed.
The pathogenic TRPM4 p.I376T variant alters channel glycosylation in a murine model but does not affect baseline cardiac electrical activity at young ages.
Answers are grounded in this paper and cite their sources.
No impact on young patient arrhythmia management; leaves open glycosylation's role in TRPM4-related cardiac phenotypes.
TRPM4 is a calcium‐activated, voltage‐modulated, non‐selective cation channel expressed in various tissues, including the heart. In 2016, we reported on a large French family with progressive heart block type I carrying the variant TRPM4 p.I376T. In the present study, the aim was to investigate the consequence of the channel variant TRPM4 p.I376T in cardiac physiology in a newly generated Trpm4 knock‐in mouse line. Male and female Trpm4 knock‐in ( Trpm4 I376T/I376T ) and wild‐type mice of different young ages (12, 18, 24 and 36 weeks old) were phenotyped using surface ECGs. Western blots were performed to quantify TRPM4 protein surface expression in cardiac tissue. Finally, patch‐clamp experiments were conducted to quantify the ‘TRPM4 current’ from freshly isolated ventricular cardiomyocytes. Assessment of cardiac electrophysiology using surface ECGs indicated no significant differences between the two genotypes at any age. Western blot analyses revealed a significant decrease in the highly glycosylated fraction of the TRPM4 protein in Trpm4 I376T/I376T hearts compared with wild‐type tissues. However, this alteration did not influence the ‘TRPM4 current’ when comparing Trpm4 I376T/I376T and wild‐type cardiomyocytes. These results indicate that the TRPM4 variant, TRPM4 p.I376T, does not alter electrical activity in the murine heart at young ages but decreases the amount of highly glycosylated TRPM4 protein expressed in the heart via an unknown mechanism.
No takes yet. Share an insight, caveat, or question.
Guichard et al. (2026) studied TRPM4 p.I376T variant. TRPM4 p.I376T variant vs. Wild-type was evaluated on Cardiac electrophysiology (surface ECGs), TRPM4 protein surface expression, and TRPM4 current. The TRPM4 p.I376T variant did not alter electrical activity in young murine hearts but significantly decreased the amount of highly glycosylated TRPM4 protein expressed.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: